Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Revenue $ 40,901 $ 7,319 $ 174,810 $ 60,050
Operating expenses        
Research and development (34,304) (37,788) (109,959) (93,301)
Selling, general and administrative (21,277) (16,164) (60,092) (56,634)
Total operating expenses (55,581) (53,952) (170,051) (149,935)
Operating (loss)/profit (14,680) (46,633) 4,759 (89,885)
Interest income 2,096 2,149 4,817 4,368
Interest expense (1,109)   (1,635)  
Gain on bargain purchase       22,049
Remeasurement on bargain purchase   (106)    
Other income (expense), net (3,093) (324) (2,657) (494)
(Loss)/profit before income tax expense (16,786) (44,914) 5,284 (63,962)
Income tax expense (831) (687) (1,883) (1,992)
Segment and consolidated net (loss)/profit $ (17,617) $ (45,601) $ 3,401 $ (65,954)
Net (loss)/profit per ordinary share        
Earnings Per Share, Basic $ (0.01) $ (0.03) $ 0.00 $ (0.06)
Earnings Per Share, Diluted $ (0.01) $ (0.03) $ 0.00 $ (0.06)
Weighted average shares outstanding:        
Weighted Average Number of Shares Outstanding, Basic 1,534,613,977 1,357,849,656 1,506,565,234 1,153,791,567
Weighted Average Number of Shares Outstanding, Diluted 1,534,613,977 1,357,849,656 1,537,021,778 1,153,791,567